TITLE: CONTINUOUS GLUCOSE MONITORING VERSUS SELF-MONITORING OF BLOOD GLUCOSE TO ASSESS GLYCEMIA IN GESTATIONAL DIABETES.
Dessi Zaharieva, Jessie H Teng, May Lea Ong, Melissa H Lee, Barbora Paldus, Linda Jackson, Christine A Holihan, Alexis Shub, Sheetal Tipnis, Ohad Cohen, David Norman O'Neal, Balasubramanian Krishnamurthy
Diabetes Technology and Therapeutics | Mary Ann Liebert | Published : 2020
BACKGROUND: Gestational diabetes mellitus (GDM) management using self-monitoring blood glucose (SMBG) does not normalise pregnancy outcomes. OBJECTIVE: We aimed to conduct an observational study to explore if Continuous Glucose Monitoring (CGM) could identify elevated glucose levels not apparent in women with GDM managed using SMBG. STUDY DESIGN: A 7-day masked-CGM (iPro, Medtronic) was performed within 2 weeks of GDM diagnosis, immediately post-GDM education but prior to insulin commencement as determined by SMBG. CGM data regarding hyperglycemia (sensor glucose >126 mg/dL [06:00-00:00hrs] and > 99 mg/dL [00:00-06:00hrs] for >10% of time), time with healthcare professionals (HCP), treatment..View full abstract
This investigator-initiated study was supported by funds from Mercy Hospitals with material support Medtronic Australasia Pty. Ltd. The funding bodies had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.